What is actually driving low libido
Testosterone deficiency. This applies to both men and women. Testosterone is the primary driver of sexual desire in both sexes. Women produce testosterone in the ovaries and adrenal glands; its decline — which accelerates significantly in the perimenopausal transition — is directly associated with reduced sexual interest, arousal difficulty, and decreased response to stimulation. In men, testosterone deficiency produces analogous changes in desire and arousal.
Estrogen deficiency (women). Low estrogen produces vaginal tissue changes — reduced lubrication, thinning of the vaginal wall, increased friction during intercourse — that make sex uncomfortable or painful. When sex becomes associated with discomfort, desire predictably declines. This is a physiological mechanism, not a psychological one.
Elevated cortisol. Chronic stress suppresses both testosterone production and sexual desire through competing neurological and hormonal pathways. The stress response is biologically prioritized over reproductive function.
Medication effects. A significant number of commonly prescribed medications — antidepressants (particularly SSRIs), oral contraceptives, antihypertensives, and others — directly suppress libido as a side effect. This is underreported and underrecognized.
Relationship and psychological context. This is real and deserves acknowledgment. Clinical evaluation distinguishes the physiological from the contextual — both can be present simultaneously.
Why "it's just stress" doesn't fully explain it
Stress contributes. But when libido is significantly below a person's baseline and has declined progressively over months or years, stress alone rarely explains the full picture. The hormonal changes of mid-life are real, measurable, and directly implicated in the sexual function changes that accompany them.
The clinical approach at Revitalize
Sexual wellness evaluation at Revitalize starts with a complete hormonal panel. Testosterone — free and total — estradiol, and DHEA are the primary analytes for libido assessment. The clinical conversation includes medication history, sleep, stress load, and relationship context. For patients with demonstrable hormonal deficits, optimization typically produces meaningful improvement in desire, arousal, and satisfaction. PRP-based treatments (O-Shot for women, erectile dysfunction evaluation and treatment for men) address vascular and tissue-level contributors beyond the hormonal picture.